KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in TaxesDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and Equipment
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gsk (GSK) Change in Inventory (2017)

Historic Change in Inventory for Gsk (GSK) over the last 8 years, with Q4 2017 value amounting to -$612.1 million.

  • Gsk's Change in Inventory changed N/A to -$612.1 million in Q4 2017 from the same period last year, while for Dec 2017 it was -$1.5 billion, marking a year-over-year change of. This contributed to the annual value of $68.1 million for FY2018, which is 11146.93% up from last year.
  • As of Q4 2017, Gsk's Change in Inventory stood at -$612.1 million.
  • Gsk's 5-year Change in Inventory high stood at $153.8 million for Q4 2013, and its period low was -$838.1 million during Q4 2014.
  • Over the past 4 years, Gsk's median Change in Inventory value was -$390.2 million (recorded in 2015), while the average stood at -$366.2 million.
  • Per our database at Business Quant, Gsk's Change in Inventory surged by 15886.78% in 2013 and then plummeted by 64491.8% in 2014.
  • Quarter analysis of 4 years shows Gsk's Change in Inventory stood at $153.8 million in 2013, then crashed by 644.92% to -$838.1 million in 2014, then soared by 79.9% to -$168.4 million in 2015, then crashed by 263.36% to -$612.1 million in 2017.
  • Its Change in Inventory stands at -$612.1 million for Q4 2017, versus -$168.4 million for Q4 2015 and -$838.1 million for Q4 2014.